CereVasc, Inc. announced the randomization of the first patient in the multicenter STRIDE clinical trial of the company’ ...

CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced ...

Neuro-Spinal Optica – has been brought out by Balaji Pai S., Special Officer of the State-run Trauma and Emergency Care Centre (TECC) on Victoria Hospital campus and Professor of neurosurgery at ...

Algernon NeuroScience has appointed Dr. Sandor Nardai as the Principal Investigator for its upcoming randomized, double-blind, placebo-controlled Phase 2a DMT study of 40 stroke patients in Europe.

There’s new wisdom about a brain diagnosis that shouldn’t be ignored. Research consistently shows that experiencing a stroke significantly increases the risk of developing cognitive decline and ...

A recent study published in the Journal of Stroke and Cerebrovascular Diseases identified fibrinogen as a potential ...

Undergrad: Ramapo College of New Jersey Med School: George Washington School of Medicine and Health Sciences Dr. Justin M. Cappuzzo was born and raised in Northern New Jersey. He attended Ramapo ...

The one-year, CAST-accredited Endoscopic Endovascular Fellowship at the University of Alabama at Birmingham offers comprehensive subspecialty training in endovascular neurosurgery. The program closely ...

Jan. 30, 2025 — An artificial intelligence (AI) model designed to predict a person's biological age (age of body cells and tissues) based on electrocardiogram (ECG) data found a strong ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Background We aimed to describe neuroimaging features, clinical profiles and long-term outcomes in patients with iatrogenic cerebral amyloid angiopathy (iCAA). Methods We performed a systematic ...